| scholarly article | Q13442814 |
| P50 | author | Donald E Low | Q60650638 |
| Andrew E Simor | Q106114444 | ||
| P2093 | author name string | K R Forward | |
| P A Franks | |||
| R Rennie | |||
| Canadian Piperacillin/Tazobactam Study Group | |||
| P2860 | cites work | A functional classification scheme for beta-lactamases and its correlation with molecular structure | Q24677460 |
| Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Tre | Q34722117 | ||
| Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate | Q35343060 | ||
| Study of the comparative activity of piperacillin/tazobactam with currently available antibiotics against 8206 aerobic isolates | Q35891315 | ||
| Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections | Q36758337 | ||
| Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group. | Q37889386 | ||
| Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential | Q40389389 | ||
| Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients. | Q40723790 | ||
| Piperacillin/tazobactam: a critical review of the evolving clinical literature | Q41125741 | ||
| In vitro activity of β-lactamase inhibitors against clinical isolates of Acinetobacter species | Q43808550 | ||
| Review of piperacillin/tazobactam in the treatment of bacteremic infections and summary of clinical efficacy. | Q54200563 | ||
| Piperacillin/tazobactam in the treatment of polymicrobial infections. | Q54200566 | ||
| Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations. | Q54297168 | ||
| Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases. | Q54331490 | ||
| Activity of ticarcillin/clavulanate and piperacillin/tazobactam (YTR 830; CL-298,741) against clinical isolates and against mutants derepressed for class I beta-lactamase. | Q54342220 | ||
| Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830). | Q54342227 | ||
| Piperacillin/tazobactam in complicated urinary tract infections. | Q54631175 | ||
| Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study | Q72544894 | ||
| Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam | Q72570609 | ||
| Piperacillin/tazobactam compared with ticarcillin/clavulanate in community-acquired bacterial lower respiratory tract infection | Q72574046 | ||
| Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections | Q72951194 | ||
| Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections | Q72956661 | ||
| The efficacy and safety of piperacillin/tazobactam in the therapy of bacteraemia | Q72956667 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | piperacillin/tazobactam | Q7197337 |
| P304 | page(s) | 33-44 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Canadian Journal of Infectious Diseases & Medical Microbiology | Q5030243 |
| P1476 | title | Cross-Canada survey of resistance of 2747 aerobic blood culture isolates to piperacillin/tazobactam and other antibiotics | |
| P478 | volume | 9 |
| Q35649669 | In vitro activity of cefepime against multidrug-resistant Gram-negative bacilli, viridans group streptococci and Streptococcus pneumoniae from a cross-Canada surveillance study |
| Q37710970 | Methicillin-resistant Staphylococcus aureus in Canada: a historical perspective and lessons learned |
| Q33649676 | Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections |
Search more.